14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $28.76 $33.00 Wednesday, 24th Apr 2024 GLPG stock ended at $28.77. This is 2.31% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 2.12% from a day low at $28.76 to a day high of $29.37.
90 days $28.76 $40.34
52 weeks $28.76 $45.16

Historical Galapagos NV prices

Date Open High Low Close Volume
Sep 24, 2020 $133.80 $134.47 $130.63 $132.47 469 243
Sep 23, 2020 $139.16 $139.71 $136.93 $137.04 125 497
Sep 22, 2020 $137.42 $137.80 $135.69 $137.44 104 678
Sep 21, 2020 $137.22 $139.77 $135.80 $139.67 134 296
Sep 18, 2020 $140.02 $140.29 $138.05 $139.27 95 190
Sep 17, 2020 $137.53 $141.60 $137.36 $141.11 102 858
Sep 16, 2020 $137.46 $138.18 $136.64 $137.05 108 201
Sep 15, 2020 $136.43 $138.20 $135.21 $135.61 122 643
Sep 14, 2020 $135.18 $136.45 $133.60 $134.95 229 746
Sep 11, 2020 $137.86 $137.95 $134.94 $136.85 414 068
Sep 10, 2020 $130.08 $130.15 $125.78 $125.80 74 057
Sep 09, 2020 $125.74 $129.25 $125.58 $127.84 100 648
Sep 08, 2020 $118.96 $124.79 $118.49 $122.47 175 755
Sep 04, 2020 $122.08 $123.63 $117.85 $123.04 152 665
Sep 03, 2020 $130.53 $130.73 $125.34 $127.00 130 749
Sep 02, 2020 $130.16 $132.22 $128.92 $131.84 120 561
Sep 01, 2020 $133.73 $133.81 $130.58 $130.91 103 038
Aug 31, 2020 $133.60 $137.43 $132.70 $133.16 190 317
Aug 28, 2020 $129.08 $132.22 $128.52 $130.95 128 114
Aug 27, 2020 $131.71 $132.21 $129.45 $130.39 109 654
Aug 26, 2020 $134.19 $134.75 $132.93 $134.19 86 351
Aug 25, 2020 $129.64 $132.24 $128.39 $131.76 177 402
Aug 24, 2020 $136.48 $136.88 $134.14 $134.83 163 455
Aug 21, 2020 $138.37 $139.06 $136.52 $137.16 246 915
Aug 20, 2020 $142.39 $144.65 $141.59 $143.52 225 836
Click to get the best stock tips daily for free!

About Galapagos NV

Galapagos NV Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative colitis, small bowel CD, fistulizing CD, ankylosing spondylitis, psoriatic arthritis, and uveitis. The compan... GLPG Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT